Literature DB >> 7977486

Nephrotic syndrome associated with agnogenic myeloid metaplasia.

M A Perazella1, G K Buller.   

Abstract

Agnogenic myeloid metaplasia (AMM), a myeloproliferative disorder of clonal origin, can affect the kidneys via several mechanisms. Associated disorders include asymptomatic interstitial extramedullary hematopoiesis, obstructive uropathy and nephrolithiasis. Currently, there are no descriptions of the nephrotic syndrome associated with AMM. We present a case of AMM associated with the nephrotic syndrome, a mesangial proliferative glomerular lesion and extramedullary hematopoiesis.

Entities:  

Mesh:

Year:  1994        PMID: 7977486     DOI: 10.1159/000168720

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  5 in total

Review 1.  Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis.

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Nat Rev Nephrol       Date:  2010-12-14       Impact factor: 28.314

2.  WITHDRAWN: Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era.

Authors:  Rachele Del Sordo; Rachele Brugnano; Carla Covarelli; Gioia Fiorucci; Franca Falzetti; Giorgio Barbatelli; Emidio Nunzi; Angelo Sidoni
Journal:  Clin Nephrol       Date:  2017-07-24       Impact factor: 0.975

3.  Renal extramedullary hematopoiesis: interstitial and glomerular pathology.

Authors:  Mariam P Alexander; Samih H Nasr; Paul J Kurtin; Edward T Casey; Loren P Herrera Hernandez; Mary E Fidler; Sanjeev Sethi; Lynn D Cornell
Journal:  Mod Pathol       Date:  2015-10-09       Impact factor: 7.842

4.  Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era.

Authors:  Rachele Del Sordo; Rachele Brugnano; Carla Covarelli; Gioia Fiorucci; Franca Falzetti; Giorgio Barbatelli; Emidio Nunzi; Angelo Sidoni
Journal:  Clin Nephrol Case Stud       Date:  2017-07-24

5.  Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL-Negative Myeloproliferative Neoplasms.

Authors:  Julie Belliere; Magali Colombat; Clément Kounde; Christian Recher; David Ribes; Antoine Huart; Dominique Chauveau; Véronique Demas; Isabelle Luquet; Odile Beyne-Rauzy; Suzanne Tavitian; Stanislas Faguer
Journal:  Kidney Int Rep       Date:  2020-12-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.